Updates on Legal Developments in the EU Life Sciences Industry
Article originally published in the Briefing paper for the BioIndustry Association on October 9, 2012
Background:
This note provides an introduction to trade marks and designs, from a European perspective. It aims to explain the relevance of trade marks and designs to bioscience companies. It has been prepared by Morag…
Continue Reading Trade Marks and Designs: Basic Facts
Article originally published in PLC Life Sciences Handbook 2009/2010
Many life science companies rely on their employees’ inventiveness to fuel their research and development (R&D) efforts and generate patents. The most successful inventions can generate billions of euros of sales annually. In some circumstances, the employees who created the patentable…
Continue Reading Employee’s Rights to Compensation for Inventions – a European Perspective
Article originally published in Concurrences, N° 3-2009 (September 2009)
PROCEED WITH CAUTION ACROSS THE IP/COMPETITION INTERSECTION
DG Competition’s release of its long-awaited Final Report on its Pharmaceutical Sector Inquiry on 8 July 2009 was somewhat of a damp squib compared to the fireworks surrounding the publication of its Interim Report…
Continue Reading The Outcome of the EC Pharmaceutical Sector Inquiry
Article originally published in Global Competition Policy, February 2009
The release of DG Competition’s Preliminary Report on its Pharmaceutical Sector Inquiry on November 28, 2008 was a Brussels media event, with press briefings, press releases, and an all-day public hearing that was covered by the Commission’s live television channel.1 …
